Long-term results of CD34+ cell transplantation in children with neuroblastoma
✍ Scribed by Kanold, Justyna ;Yakouben, Karima ;Tchirkov, Andrei ;Carret, Anne-Sophie ;Vannier, Jean-Pierre ;LeGall, Edouard ;Bordigoni, Pierre ;Dem�ocq, Fran�ois
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 117 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Survivors of allogeneic marrow transplants are immunodeficient for at least 1 year after grafting. Multiple defects of immunity have been found; however, it is not known which defect primarily accounts for the high infectious morbidity of these patients. Twenty-nine allograft recipients who were in
A retrospective analysis of 46 histologically proven cases of neuroblastoma is presented. The over-all 2-year survival was 46%. All except 1 of the 21 patients surviving 2 years were continuously free of clinical and laboratory evidence of neuroblastoma. The patients treated before 1967 were treated
## Abstract ## Objective To assess the safety and efficacy of intensive immunosuppression followed by T cell–depleted autologous hematopoietic stem cell transplantation (ASCT) for induction of disease remission in children with refractory progressive juvenile idiopathic arthritis (JIA). ## Method